Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-006199

Chief Commercial Officer sold 10,000 shares at $48.00 ($480,006)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Weinberg Eric Chief Commercial Officer 2024-01-22 Sale 10b5-1 −10,000 $48.00 $480,006 309,978 I
Open-market sales · 10,000 sh · avg $48.00 · $480,006
Loading xslF345X05/ownership.xml…